demethoxycurcumin and Pneumonia

demethoxycurcumin has been researched along with Pneumonia* in 1 studies

Other Studies

1 other study(ies) available for demethoxycurcumin and Pneumonia

ArticleYear
Multi-walled carbon nanotube-induced inhalation toxicity: Recognizing nano bis-demethoxy curcumin analog as an ameliorating candidate.
    Nanomedicine : nanotechnology, biology, and medicine, 2018, Volume: 14, Issue:6

    Human beings and ecosystems are being possibly exposed to CNTs, as there is a rise in global production rate of carbon nanotubes (CNTs). This may affect the health of humans and increases the environmental risk. We have already reported the pulmonary toxicity due to the inhalation of MWCNTs. We claim that a compound with anti-inflammatory and antioxidant activity may ameliorate the CNT-induced toxic effect. With this view, we have investigated the ameliorative effect of intravenously-administered nano bis-demethoxy curcumin analog (NBDMCA) against MWCNTs-induced inhalation toxicity by examining the lung histopathology for inflammatory cell dynamics, pulmonary remodeling and estimating the inflammatory biomarkers in the broncho-alveolar lavage fluid. We observed that NBDMCA could ameliorate the injury as evidenced by the decline in the levels of markers of inflammation, cell damage, and the histopathological changes induced by MWCNTs. We conclude that NBDMCA may be used to reduce the risk of MWCNTs-induced inhalation toxicity.

    Topics: Administration, Inhalation; Animals; Antineoplastic Agents; Curcumin; Cytokines; Diarylheptanoids; Male; Nanotubes, Carbon; Oxidative Stress; Pneumonia; Rats; Rats, Wistar

2018